MedElevator Войти в исследования
← Поиск публикаций

DOI 10.15586/aei.v53i3.1277

Медицинская библиотека · Allergologia et immunopathologia · 2025

Corticosteroid prescription in children with respiratory symptoms: A real-life study.

Contreras Remedios Cárdenas, Mena Alicia Habernau, Díaz Elisa Haroun, Hornillos Javier Ruíz, Pérez Margarita Tomás, Pineda Rafael Pineda, Luis Elena Mederos, Labrador Maria Ángeles González, Ana Rosadoi, García Silvia Sánchez, Pérez Eloísa Rubio, Cueva Ignacio Salamanca de la

СтатьяНаблюдательное исследованиеМногоцентровое исследованиеПеревод в очереди

Аннотация

Asthma is one of the most common childhood diseases. Most children respond to low doses of corticosteroids and/or anti-leukotrienes. However, a small percentage remain symptomatic. They require high doses of inhaled corticosteroids (ICS) and anti-leukotrienes, sometimes with long-acting bronchodilators (LABA) and occasionally systemic corticosteroids (SC). However, we frequently observe that the only treatment they receive for exacerbations is short-acting beta-agonists (SABA) and oral corticosteroids (OC) without adding ICS as a maintenance treatment to prevent new episodes. This leads to frequent exacerbations, airflow limitation, and significant alterations in the quality of life. In addition, this results in high resource consumption, frequent emergency room visits, and school absenteeism, leading to absence from work for caregivers. A descriptive, retrospective, observational, and multicenter study was carried out on patients under 12 years of age, who attended pediatric allergy consultations for the first time. The main objective was to determine the consumption of SCs because of respiratory exacerbations in the year before the first consultation. Data were obtained from 144 children, 58.3% male, with a median age of 5 years. It was found that during the year before attending our clinic, 70% had perennial symptoms and were only prescribed with salbutamol on demand when they presented with respiratory symptoms. They had not been prescribed with ICS or anti-leukotrienes. They required attention in the emergency room of their nearest health center or hospital on an average of three times per year. During these exacerbations, almost 75% received SCs(prednisolone), with an average of 2.6 annual cycles (0-12) prescribed in more than half of the cases in the emergency room. In over 80% of the cases, the effects of SC abuse were not previously monitored. The overuse of SC in atopic children with respiratory symptoms was confirmed in our group, which requires considering behavioral changes.

Для цитирования: Contreras Remedios Cárdenas, Mena Alicia Habernau, Díaz Elisa Haroun, Hornillos Javier Ruíz, Pérez Margarita Tomás, Pineda Rafael Pineda, Luis Elena Mederos, Labrador Maria Ángeles González, Ana Rosadoi, García Silvia Sánchez, Pérez Eloísa Rubio, Cueva Ignacio Salamanca de la. Corticosteroid prescription in children with respiratory symptoms: A real-life study.. Allergologia et immunopathologia. 2025. DOI: 10.15586/aei.v53i3.1277.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.